| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.00027 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.00028 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0002 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.00015 | 1 |